MONITA S YUEN-GREEN
Allopathic & Osteopathic Physicians|Internal Medicine UKIAH, CA NPI 1013000868
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine CA Novo Nordisk AS All categories
General Payments — all program years on this page
$2,631.31
- Category: General Payments
- Program years: PY2018–2024
- Record count: 124
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $198.75 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $198.75 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $72.83 | 3 |
| ABBVIE INC. | $31.50 | 1 |
| Lilly USA, LLC | $26.99 | 1 |
| Acerta Pharma LLC | $25.72 | 1 |
| PFIZER INC. | $23.11 | 1 |
| GlaxoSmithKline, LLC. | $18.60 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1096661460 | Novo Nordisk Inc | $30.05 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097199792 | Novo Nordisk Inc | $21.43 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097292993 | Novo Nordisk Inc | $21.35 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103833450 | ABBVIE INC. | $31.50 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104720531 | AstraZeneca Pharmaceuticals LP | $25.72 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115812573 | GlaxoSmithKline, LLC. | $18.60 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1132029347 | PFIZER INC. | $23.11 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135259455 | Lilly USA, LLC | $26.99 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.